Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocan Diagnostics is a Canadian in vitro diagnostics company that develops, manufactures, and distributes rapid and ELISA-based diagnostic tests. The company markets its products under the Tell Me Fast brand and focuses on point-of-care and laboratory testing across infectious diseases, women’s health, cardiac and cancer markers, drugs-of-abuse screening, and food safety. Biocan states that it operates sales, R&D, and manufacturing activities from Coquitlam, British Columbia, and manufactures products in an ISO 13485:2016 MDSAP-certified facility. Its business appears to be primarily commercial rather than therapeutic drug development, with offerings aimed at hospitals, clinics, laboratories, field settings, and home use. The company is healthcare-related, but it is best characterized as an IVD manufacturer rather than a biotech therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biocan Diagnostics.